Researchers identified RNA-associated amyloid fibrils in human seminal fluid and demonstrated that synthetic PAP fibrils ...

A long noncoding RNA called CYP4A22-AS1 promotes radioresistance in cervical adenocarcinoma by shuttling YBX1 into the ...

Rotow, MD, explains how RNA-based next-generation sequencing (NGS) fits into testing for newly diagnosed advanced nonsquamous non-small cell lung cancer (NSCLC) in a discussion moderated by Matthew A.

A Nature Genetics analysis of GTEx tissues and seven phenotypes shows that annotation and quantification method choices ...

Tempus xR RNA sequencing assay receives EU IVDR Class C certification, supporting continued clinical and biopharma access in ...

Tempus AI, Inc. Enters Into Multi-Year Agreement With Bristol Myers Squibb To License Multimodal Oncology Data CI Oct. 23 Pathos AI Announces Strategic Collaborations With Bristol Myers Squibb And ...

Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European Union's In Vitro Diagnostic Regulation (IVDR) as a Class C in vitro diagnostic device. The ...

Precision-cut lung slices allow researchers to study living human lung tissue outside the body, preserving the different cell ...

Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European Union’s In ...

According to MarketsandMarkets™, the Next-generation Sequencing Services Market is projected to reach USD 9.37 billion by ...

New RNA extraction techniques overcome barriers to help scientists better evaluate treatments for diseases such as pulmonary ...